Elequin Capital’s DexCom DXCM Stock Holding History

Elequin Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67	Sell	1 -12	-92%	-$799	﹤0.01%	673
2026 Q1	$816	Sell	13 -37	-74%	-$2.58K	﹤0.01%	554
2025 Q4	$3.32K	Buy	+50	New	+$3.23K	﹤0.01%	339
2025 Q1	–	Sell	-128	Closed	-$9.96K	–	407
2024 Q4	$9.96K	Buy	128 +41	+47%	+$3.04K	﹤0.01%	332
2024 Q3	$5.83K	Buy	+87	New	+$7.14K	﹤0.01%	284
2024 Q2	–	Sell	-306	Closed	-$42.4K	–	231
2024 Q1	$42.4K	Buy	+306	New	+$38.5K	0.01%	32
2022 Q3	–	Sell	-1,262	Closed	-$94K	–	590
2022 Q2	$94K	Buy	1,262 +30	+2%	+$2.74K	0.02%	115
2022 Q1	$158K	Buy	+1,232	New	+$135K	0.03%	19

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Elequin Capital's DXCM Position: Q2 2026 in Review

Elequin Capital reduced its DexCom (DXCM) stake by 92% in Q2 2026, selling an estimated $799 and leaving 1 share worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Elequin Capital first reported a position in DXCM in Q1 2022 and has held it in 8 quarters since. The position peaked at $158K in Q1 2022. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Elequin Capital held 1 share of DexCom worth $67 as of Q2 2026.
Elequin Capital sold 12 DexCom shares in Q2 2026, an estimated $799.
DexCom made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #673 holding.
Elequin Capital first reported a position in DexCom in Q1 2022 and has held it in 8 quarters since.
Elequin Capital's DexCom position peaked at $158K in Q1 2022.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.